CGON
Price
$51.92
Change
-$0.64 (-1.22%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
4.34B
51 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$48.08
Change
-$4.38 (-8.35%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
2.27B
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs DNTH

Header iconCGON vs DNTH Comparison
Open Charts CGON vs DNTHBanner chart's image
CG Oncology
Price$51.92
Change-$0.64 (-1.22%)
Volume$18.07K
Capitalization4.34B
Dianthus Therapeutics
Price$48.08
Change-$4.38 (-8.35%)
Volume$32.77K
Capitalization2.27B
CGON vs DNTH Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. DNTH commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and DNTH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CGON: $52.56 vs. DNTH: $52.46)
Brand notoriety: CGON and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 116% vs. DNTH: 109%
Market capitalization -- CGON: $4.34B vs. DNTH: $2.27B
CGON [@Biotechnology] is valued at $4.34B. DNTH’s [@Biotechnology] market capitalization is $2.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while DNTH’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 5 bearish.
  • DNTH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CGON and DNTH are a good buy in the short-term.

Price Growth

CGON (@Biotechnology) experienced а -4.61% price change this week, while DNTH (@Biotechnology) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

CGON is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($4.34B) has a higher market cap than DNTH($2.27B). DNTH (27.299) and CGON (26.590) have similar YTD gains . DNTH has higher annual earnings (EBITDA): -139.9M vs. CGON (-179.53M). CGON has more cash in the bank: 680M vs. DNTH (403M). DNTH has less debt than CGON: DNTH (1.29M) vs CGON (7.24M). DNTH has higher revenues than CGON: DNTH (3.08M) vs CGON (2.17M).
CGONDNTHCGON / DNTH
Capitalization4.34B2.27B191%
EBITDA-179.53M-139.9M128%
Gain YTD26.59027.29997%
P/E RatioN/A3.24-
Revenue2.17M3.08M71%
Total Cash680M403M169%
Total Debt7.24M1.29M564%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONDNTH
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 29 days ago
76%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBHVX16.720.26
+1.58%
Segall Bryant & Hamill Sm Cp Val Ins
GSINX23.540.22
+0.94%
Goldman Sachs GQG Ptnrs Intl Opps Inv
JISCX25.070.19
+0.76%
Janus Henderson Small Cap Value S
RGREX9.430.05
+0.53%
Invesco Global Real Estate R
TSRLX82.49-1.12
-1.34%
Touchstone Large Cap Focused R6

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-3.28%
IDYA - CGON
57%
Loosely correlated
+0.50%
ACLX - CGON
54%
Loosely correlated
-0.01%
SYRE - CGON
53%
Loosely correlated
+1.65%
NUVL - CGON
53%
Loosely correlated
+2.12%
BHVN - CGON
52%
Loosely correlated
-3.06%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with VRDN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-1.35%
VRDN - DNTH
44%
Loosely correlated
-3.92%
SYRE - DNTH
43%
Loosely correlated
+1.65%
CGON - DNTH
43%
Loosely correlated
-3.28%
ORKA - DNTH
43%
Loosely correlated
+0.73%
XNCR - DNTH
43%
Loosely correlated
-0.99%
More